Phase 2 Readout~quarter

Phase 2 Readout: casdatifan

Other upcoming events for RCUS

Phase 3 ReadoutPhase 3 Topline: A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chem
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib
Patent ExpiryPatent/Exclusivity Expiry: PEMETREXED

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 2 Readout: casdatifan — RCUS Phase 2 Readout | BioSniper